Cost-Utility Analysis and Budget Impact Analysis of Eculizumab and Ravulizumab Compared to Plasmapheresis for Atypical Hemolytic Uremic Syndrome in Thailand

Kidney Medicine · Elsevier

Аннотация

Publication date: Available online 5 November 2026 Source: Kidney Medicine Author(s): Sutinee Soopairin, Janewit Wongboonsin, Chanthawat Patikorn, Parnnaphat Luksameesate, Ratana Chawanasunthornpoj, Suthira Taychakhoonavudh

Читать у издателя →

Похожие статьи